Popular Articles

Shire Receives Fast Track Designation For Velaglucerase Alfa For Gaucher Disease
Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announces it has received Fast Track designation from the U.S. Food and Drug Administration (FDA) for velaglucerase alfa, its enzyme replacement therapy in development for the treatment of Type I Gaucher disease. Shire is working with the FDA to determine subsequent steps and timing for the filing of its NDA.
generic viagra online
Diabetes UK Launches Its National Measure Up Roadshows
Diabetes UK launches its national Measure Up Roadshow today to tackle the diabetes epidemic, as it reveals that more than 1.7 million people in the UK could have avoided developing Type 2 diabetes.
News of the day
More Obese Blacks Than Hispanics And Whites In The US
The incidence of obesity among US blacks is higher than among Hispanics and non-Hispanic whites, reports the Centers for Disease Control and
Medical Devices

New Drive To Save Lives From Venous Thromboembolism In Hospital Patients, UK

The Chief Medical Officer, Sir Liam Donaldson and the All Party Parliamentary Thrombosis Group are today holding a leadership summit on venous thromboembolism (VTE) in the NHS. Health Minister, Ann Keen, the All Party Chair, John Smith MP, and NHS Medical Director, Sir Bruce Keogh are among the speakers at event to raise awareness of the Department of Health"s prevention strategy for VTE. NHS senior managers will learn of the comprehensive and important drive to save lives from this important cause of avoidable death. The Department of Health is committed to reducing the number of people who develop blood clots by encouraging staff to follow national policy which states that all adult patients in England receive a VTE risk assessment on admission to hospital. At the event today, best practice regional VTE prevention initiatives will be showcased and Strategic Health Authorities will be encouraged to develop their own initiatives. A new online educational re (e-learning) to inform clinicians and help them to assess a patient"s risk of VTE and take appropriate preventative measures will also be launched. Chief Medical Officer, Sir Liam Donaldson said: "The dangers of venous thromboembolism in hospitalised patients have long been recognised. By working with NHS organisations, clinicians and managers and with the medical Royal Colleges we can ensure that all NHS staff and students recognise the dangers of VTE in hospitalised patients. "By following standardised national preventive strategy that assesses the risk of VTE and by taking the right preventative measures, there is the potential to save thousands of lives each year." John Smith MP, Chair All Party Parliamentary Thrombosis Group said, "People often forget the scale of the problem we face. VTE is causes 10% of all hospital deaths annually and for those who survive a blood clot, the long term impact on health can be devastating. We hope all hospitals take notice of today"s message - VTE risk assessment for hospital patients is not optional - it is a vital life saving measure." Health Minister, Ann Keen said, "Patient safety is a priority for this Government. The national VTE risk assessment guidance that the Department of Health launched in September 2008 is a world first in a national preventative strategy of this scale. "Today"s summit will help NHS staff to recognise VTE in the hospital setting as a major cause of avoidable death and ensure that all patients receive a risk assessment upon admission to hospital." Dept. of Health, UK


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):